diabetic
-
Biologics
Royal Biologics Completes 100th Cryo Cord™ Case, Successfully Enrolls First Patient Into Diabetic Foot Ulcer Study
HACKENSACK, N.J., September 18, 2020 (Newswire.com) – Royal Biologics, an ortho-biologics company specializing in the research and advancement of novel ortho-biologics…
Read More » -
Extremities
SANUWAVE Announces Cooperation with Ortho-Medico in Europe on a New 100 Subject Trial Treating Patients with Diabetic Foot Ulcers In-Home Care Using Dermapace
SUWANEE, GA / ACCESSWIRE / December 15, 2016 / SANUWAVE Health, Inc. (OTC QB: SNWV) is pleased to announce that…
Read More » -
Extremities
Clinical Study in UK to Evaluate ReGenerCell for Diabetic Foot Ulcer Treatment
NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM — (Marketwired) — 05/30/16 — Avita Medical Ltd. (ASX: AVH) (OTCQX:…
Read More » -
Extremities
Integra LifeSciences Receives FDA Approval of Integra® Dermal Regeneration Template (IDRT) for Treatment of Chronic Diabetic Foot Ulcers (DFU)
PLAINSBORO, N.J., Jan. 07, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that the United States Food and Drug…
Read More » -
Biologics
For Diabetics, Treatment with Stem Cells May Avert Amputation
PHOENIX, Feb. 18, 2015 /PRNewswire-USNewswire/ — According to data presented at the 73rd Annual Scientific Conference of the American College of Foot and Ankle…
Read More »